Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
$ARVN 🇺🇸 Arvinas "The Eighth Building 5 Lease Amendment.. include approximately an additional approximately 9,700 sqft for a total of approximately 73,700 sqft and sets forth the monthly base rent during the extended term. From January 1, 2025 to December 31, 2025" https://t.co/jlDbOMYyg3
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations $NRXP $PSIL https://t.co/kFglBvYgG4
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Signing of Binding Term Sheet for $27 Million in Funding for HOPE Clinic Acquisitions and Pharmaceutical Operations $NRXP https://t.co/kFglBvYgG4
Renovaro has announced plans to acquire Predictive Oncology in an all-stock transaction. The deal, which involves the issuance of preferred stock, is structured as a binding letter of intent (LOI). Predictive Oncology, traded under the ticker symbol $POAI, was previously valued at a market cap of $4 million. Details regarding the acquisition are still pending, and further updates are anticipated as the transaction progresses. This acquisition aligns with Renovaro's strategy to expand its portfolio in the biotechnology sector.